IMMUNOSCINTIGRAPHY OF HODGKINS-DISEASE - INVIVO USE OF RADIOLABELED MONOCLONAL-ANTIBODIES DERIVED FROM HODGKIN CELL-LINES

被引:17
|
作者
CARDE, P
DACOSTA, L
MANIL, L
PFREUNDSCHUH, M
LUMBROSO, JD
SACCAVINI, JC
CAILLOU, B
RICARD, M
BOUDET, F
HAYAT, M
DIEHL, V
PARMENTIER, C
机构
[1] UNIV COLOGNE,MED KLIN 1,W-5000 COLOGNE 41,GERMANY
[2] DORIS IND,GIF SUR YVETTE,FRANCE
[3] INSERM,F-94800 VILLEJUIF,FRANCE
关键词
D O I
10.1016/0277-5379(90)90019-P
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Hodgkin associated monoclonal antibody (Mab) HRS-1 reacts with Hodgkin and Reed-Sternberg cells (HR-S) in all HD subtypes. HRS-1 Mab was labelled with radioiodine and injected into 10 patients for immunoscintigraphy (IS). Seven patients were injected with HRS-1 Mab radiolabelled with 131I and three patients were injected with HRS-1 Mab labelled with 123I. A control anti-alpha-fetoprotein (anti-AFP) Mab was radiolabelled with another iodine isotope and was injected simultaneously in five cases. Six out of eight patients with proven HD had a true positive scan (nodal, splenic and bony involvement). Imaging was equivocal or failed in the two other patients. In the last two patients IS imaging was truly negative due to the absence of residual HD in one patient and to an erroneous histological diagnosis of HD in another patient. These results, although preliminary, demonstrate that IS with radioiodine-labelled HRS-1 Mab is feasible and may prove to be informative in the staging of HD. © 1990.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 50 条
  • [1] IMMUNOPRECIPITATION OF THE INTERLEUKIN-2 RECEPTOR FROM HODGKINS-DISEASE DERIVED CELL-LINES BY MONOCLONAL-ANTIBODIES
    SCHWARTING, R
    GERDES, J
    ZIEGLER, A
    STEIN, H
    [J]. HEMATOLOGICAL ONCOLOGY, 1987, 5 (01) : 57 - 64
  • [2] MONOCLONAL-ANTIBODIES AGAINST HODGKIN-DERIVED CELL-LINES
    PFREUNDSCHUH, M
    KRUGER, GFR
    MOMMERTZ, E
    MEISNER, M
    MOLLER, P
    DIEHL, V
    [J]. BLUT, 1986, 53 (03): : 218 - 218
  • [3] CHARACTERISTICS OF HODGKINS-DISEASE DERIVED CELL-LINES
    DIEHL, V
    KIRCHNER, HH
    BURRICHTER, H
    STEIN, H
    FONATSCH, C
    GERDES, J
    SCHAADT, M
    HEIT, W
    UCHANSKAZIEGLER, B
    ZIEGLER, A
    HEINTZ, F
    SUENO, K
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (04): : 615 - 632
  • [4] THE USE OF RADIOLABELED MONOCLONAL-ANTIBODIES FOR CELL LABELING INVIVO
    DOHERTY, PW
    WODA, B
    HNATOWICH, DJ
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1984, 25 (05) : P26 - P26
  • [5] GENOTYPES AND IMMUNOPHENOTYPES OF HODGKINS-DISEASE DERIVED CELL-LINES
    DREXLER, HG
    NORTON, J
    LEBER, BF
    HOFFBRAND, AV
    MINOWADA, J
    [J]. BLUT, 1987, 55 (04): : 248 - 248
  • [6] MONOCLONAL-ANTIBODIES FROM HUMAN CELL-LINES
    STEINITZ, M
    [J]. FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE, 1982, 311 (04): : 348 - 349
  • [7] PRODUCTION OF MULTIPLE CYTOKINES BY HODGKINS-DISEASE DERIVED CELL-LINES
    KLEIN, S
    JUCKER, M
    DIEHL, V
    TESCH, H
    [J]. HEMATOLOGICAL ONCOLOGY, 1992, 10 (06) : 319 - 329
  • [8] HETEROGENEOUS EXPRESSION OF PROTOONCOGENES IN HODGKINS-DISEASE DERIVED CELL-LINES
    JUCKER, M
    SCHAADT, M
    DIEHL, V
    POPPEMA, S
    JONES, D
    TESCH, H
    [J]. HEMATOLOGICAL ONCOLOGY, 1990, 8 (04) : 191 - 204
  • [9] HODGKINS DISEASE-DERIVED CELL-LINES - CONFLICTING CLUES FOR THE ORIGIN OF HODGKINS-DISEASE
    DREXLER, HG
    AMLOT, PL
    MINOWADA, J
    [J]. LEUKEMIA, 1987, 1 (09) : 629 - 637
  • [10] 2 NEOPLASTIC CELL-LINES WITH UNIQUE FEATURES DERIVED FROM HODGKINS-DISEASE
    SCHAADT, M
    DIEHL, V
    STEIN, H
    FONATSCH, C
    KIRCHNER, HH
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (06) : 723 - 731